Barclays Lowers Rating on Cigna Amid PBM Transition Concerns
Barclays has lowered its rating on Cigna, expressing worries about the company's transition involving its pharmacy benefit manager.
Editorial Staff
1 min read
Updated 10 days ago
On May 31, 2026, Barclays announced a downgrade of Cigna, a major player in the healthcare sector.
The downgrade is attributed to concerns surrounding the company's transition of its pharmacy benefit manager.
This move by Barclays highlights potential risks that Cigna may face during this significant operational change.